| Aug 27 |
Penumbra, Inc. to Present at the Baird Global Healthcare Conference
|
| Aug 23 |
3 US Stocks That May Be Trading Below Estimated Value In August 2024
|
| Aug 21 |
Penumbra, Inc. to Present at the Wells Fargo Healthcare Conference
|
| Aug 21 |
Penumbra sees 85.5% limb salvage rate in thrombectomy device trial
|
| Aug 20 |
Penumbra Grinding Through A Painful Growth Expectations Reset
|
| Aug 20 |
Penumbra: Growth In Its Thrombectomy Portfolio Should Lead To Strong Earnings
|
| Aug 13 |
Penumbra authorizes share buyback of up to $200M
|
| Aug 13 |
Penumbra, Inc. Announces $200 Million Share Repurchase Authorization
|
| Aug 2 |
Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference
|
| Aug 1 |
Penumbra Second Quarter 2024 Earnings: EPS Misses Expectations
|
